Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38828933

Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2024 Aug 1
First author
Hungria V

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2024 Oct 10;391(14):1364. doi: 10.1056/NEJMc2410841.
    note
    Source null
    related pmid
    39383465
    relationship
    Comment in
  2. citation
    N Engl J Med. 2024 Oct 10;391(14):1364-1365. doi: 10.1056/NEJMc2410841.
    note
    Source null
    related pmid
    39383466
    relationship
    Comment in

Authors and identifiers

  1. name
    Hungria V
    type
    Author
  2. name
    Robak P
    type
    Author
  3. name
    Hus M
    type
    Author
  4. name
    Zherebtsova V
    type
    Author
  5. name
    Ward C
    type
    Author
  6. name
    Ho PJ
    type
    Author
  7. name
    Ribas de Almeida AC
    type
    Author
  8. name
    Hajek R
    type
    Author
  9. name
    Kim K
    type
    Author
  10. name
    Grosicki S
    type
    Author
  11. name
    Sia H
    type
    Author
  12. name
    Bryant A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hungria V
    type
    Author
  2. name
    Robak P
    type
    Author
  3. name
    Hus M
    type
    Author
  4. name
    Zherebtsova V
    type
    Author
  5. name
    Ward C
    type
    Author
  6. name
    Ho PJ
    type
    Author
  7. name
    Ribas de Almeida AC
    type
    Author
  8. name
    Hajek R
    type
    Author
  9. name
    Kim K
    type
    Author
  10. name
    Grosicki S
    type
    Author
  11. name
    Sia H
    type
    Author
  12. name
    Bryant A
    type
    Author
bibliography ids
  1. nci-bib-c350c1429b3f2af000ffe966
book metadata
content sha256
d219ac6082a25b78bc1001d631a694b7ae5d9001414d00751270742451b9041c
document type
citation
dois
  1. 10.1056/NEJMoa2405090
electronic publication date
display
2024 Jun 1
precision
day
year
2024
evidence scope
bibliographic_metadata_only
id
pubmed:38828933
immutable id
pubmed:38828933@d219ac6082a25b78bc1001d631a694b7ae5d9001414d00751270742451b9041c
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
5
name
The New England journal of medicine
nlm unique id
0255562
pages
393-407
volume
391
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2024 Oct 10;391(14):1364. doi: 10.1056/NEJMc2410841.
    note
    Source null
    related pmid
    39383465
    relationship
    Comment in
  2. citation
    N Engl J Med. 2024 Oct 10;391(14):1364-1365. doi: 10.1056/NEJMc2410841.
    note
    Source null
    related pmid
    39383466
    relationship
    Comment in
outcomes validated
false
pmid
38828933
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
b1bf3cb64d8c2122d5c84f7d7bdeb2f35fa01cb4c3bd3dd5ed20024ec8994d02
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2024 Aug 1
precision
day
year
2024
publication types
  1. Journal Article
  2. Randomized Controlled Trial
  3. Clinical Trial, Phase III
  4. Multicenter Study
  5. Comparative Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/38828933/
title
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma.

Preserved source evidence · Not medical advice